Pharmaceutical affairs law in pending at National Assembly likely to pass on Aug. 31.

Published: 2000-08-01 11:06:00

Updated: 2000-08-01 11:06:00

The MDP is going to convene an extraordinary session of the National Assembly single-handedly without regard to the opposite party's participation, and may try to pass the revised bill of the pharmaceutical affairs law that drifted with current political battles between the ruling and opposition ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK